Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	42,239	27,533	33,738	28,394	18,095	24,129
Market Cap Growth	18.44%	-18.39%	18.82%	56.92%	-25.01%	171.24%
Enterprise Value	45,665	30,344	36,504	31,818	19,487	23,753
Last Close Price	421.20	274.55	336.36	283.00	186.49	248.56

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	57.52	42.88	48.44	32.96	22.70	25.18
PS Ratio	4.31	2.92	4.12	3.52	2.62	3.10
PB Ratio	6.35	4.14	5.61	5.33	5.20	8.97
P/TBV Ratio	6.41	4.18	5.67	5.39	5.21	8.99
P/FCF Ratio	302.61	197.25	71.72	-	-	128.44
P/OCF Ratio	93.57	61.00	27.53	-	-	22.71

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.65	3.21	4.45	3.94	2.82	3.05
EV/EBITDA Ratio	27.40	21.05	27.87	22.37	14.91	16.61
EV/EBIT Ratio	34.12	25.18	31.11	24.00	16.90	18.40
EV/FCF Ratio	327.16	217.39	77.60	-	-	126.44

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.61	0.61	0.56	0.63	0.96	0.24
Debt / EBITDA Ratio	2.43	2.68	2.44	2.23	2.43	0.44
Debt / FCF Ratio	-	29.00	7.15	-	-	3.43
Net Debt / Equity Ratio	0.52	0.52	0.53	0.62	0.88	0.20
Net Debt / EBITDA Ratio	2.14	2.38	2.45	2.33	2.34	0.37
Net Debt / FCF Ratio	-	24.54	6.81	-2.76	-1.43	2.81
Asset Turnover	-	0.75	0.73	0.83	1.00	1.71
Inventory Turnover	-	1.59	1.83	2.08	2.27	4.01
Quick Ratio	-	0.70	0.86	0.89	0.81	0.88
Current Ratio	-	1.55	1.61	1.61	1.61	1.72
Return on Equity (ROE)	-	10.14%	12.29%	19.57%	25.84%	43.31%
Return on Assets (ROA)	-	6.00%	6.48%	8.48%	10.43%	17.67%
Return on Invested Capital (ROIC)	9.82%	9.27%	9.72%	13.01%	17.66%	35.43%
Return on Capital Employed (ROCE)	-	14.60%	15.00%	18.40%	20.10%	38.50%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 14, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.74%	2.33%	2.06%	3.03%	4.41%	3.97%
FCF Yield	0.33%	0.51%	1.39%	-4.23%	-11.84%	0.78%
Dividend Yield	0.02%	0.04%	0.03%	0.03%	0.05%	0.04%
Payout Ratio	-	1.56%	1.44%	1.13%	1.31%	0.96%
Buyback Yield / Dilution	0.01%	0.00%	-1.79%	-1.63%	-	-
Total Shareholder Return	0.03%	0.04%	-1.76%	-1.59%	0.05%	0.04%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error